Ranbaxy suspends shipment of drugs from two plants

Uncategorized Comments (0)

The rush to market, driven by old pharma pricing models, has consequences….including manufacturing challenges. Change pricing model….change the world…..HK

Indian drug major Ranbaxy Laboratories Ltd has announced last month that it has temporarily suspended shipment from its two active pharmaceutical ingredients (API) plants in the country to examine process and controls of manufacturing at these two units.
BY  Lohit Jagwani

» Uncategorized » Ranbaxy suspends shipment of drugs...
On February 26, 2014

Leave a Reply

Your email address will not be published. Required fields are marked *

« »